Page last updated: 2024-08-20

perylene and Cancer of Pituitary

perylene has been researched along with Cancer of Pituitary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chin, SS; Cole, CD; Couldwell, WT; Liu, JK; Schmidt, MH; Sheng, X; Weiss, MH1
Chen, ZH; Couldwell, WT; Gopalakrishna, R; Hamilton, HB; Hinton, DR; Law, RE; Su, YZ; Weiss, MH1
Cerman, J; Mareková, M; Vávrová, J; Vokurková, D1

Other Studies

3 other study(ies) available for perylene and Cancer of Pituitary

ArticleYear
Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor model.
    Journal of neuro-oncology, 2008, Volume: 87, Issue:3

    Topics: Animals; Anthracenes; Apoptosis; In Situ Nick-End Labeling; Perylene; Photochemotherapy; Pituitary Neoplasms; Radiation-Sensitizing Agents; Rats; Rats, Wistar

2008
Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: potential therapeutic application.
    Journal of neurosurgery, 1996, Volume: 85, Issue:2

    Topics: Adenoma; Animals; Anthracenes; Apoptosis; Cell Division; Perylene; Pituitary Neoplasms; Protein Kinase C; Rats; Tumor Cells, Cultured

1996
Light-induced photoactivation of hypericin inhibits cellular growth in pituitary adenoma cell line AtT20/D16v-F2 (hypericin inhibits cellular growth of AtT20/D16v-F2).
    Acta medica (Hradec Kralove), 2001, Volume: 44, Issue:1

    Topics: Adenoma; Animals; Anthracenes; Apoptosis; Cell Cycle; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Radiation; HL-60 Cells; Humans; Light; Mice; Perylene; Photosensitizing Agents; Pituitary Neoplasms; Protein Kinase C; Tumor Cells, Cultured

2001